Stryker Corporation $SYK Stock Position Reduced by Heritage Family Offices LLP

Heritage Family Offices LLP lessened its stake in Stryker Corporation (NYSE:SYK) by 46.0% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 3,275 shares of the medical technology company’s stock after selling 2,795 shares during the quarter. Heritage Family Offices LLP’s holdings in Stryker were worth $1,151,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in SYK. Clayton Financial Group LLC purchased a new position in shares of Stryker during the 3rd quarter valued at $26,000. United Financial Planning Group LLC purchased a new stake in shares of Stryker during the third quarter worth $27,000. Elevation Point Wealth Partners LLC purchased a new stake in shares of Stryker during the second quarter worth $28,000. Kilter Group LLC acquired a new stake in Stryker during the second quarter valued at $29,000. Finally, Howard Hughes Medical Institute purchased a new position in Stryker in the second quarter valued at about $29,000. Hedge funds and other institutional investors own 77.09% of the company’s stock.

Analysts Set New Price Targets

Several brokerages have weighed in on SYK. Needham & Company LLC upped their target price on Stryker from $448.00 to $454.00 and gave the stock a “buy” rating in a research report on Friday, January 30th. Evercore set a $390.00 price target on Stryker in a research note on Monday, January 5th. UBS Group dropped their price objective on Stryker from $400.00 to $380.00 and set a “neutral” rating on the stock in a report on Tuesday, March 17th. The Goldman Sachs Group set a $399.00 target price on shares of Stryker in a research note on Friday, January 9th. Finally, Raymond James Financial raised shares of Stryker from a “market perform” rating to an “outperform” rating and set a $418.00 target price for the company in a research report on Tuesday, January 6th. Fourteen analysts have rated the stock with a Buy rating and five have issued a Hold rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $427.50.

Insider Activity at Stryker

In other news, Director Ronda E. Stryker sold 250,000 shares of the company’s stock in a transaction that occurred on Wednesday, February 4th. The stock was sold at an average price of $362.92, for a total transaction of $90,730,000.00. Following the completion of the transaction, the director directly owned 2,457,331 shares in the company, valued at $891,814,566.52. The trade was a 9.23% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 5.20% of the stock is currently owned by company insiders.

Key Headlines Impacting Stryker

Here are the key news stories impacting Stryker this week:

• Positive Sentiment: Stryker says the cybersecurity incident is contained and that restoration is underway, which reduces immediate operational uncertainty. Stryker confirms cyberattack is contained and restoration underway
• Positive Sentiment: Company reports progress in restoration and that operations are stabilizing, suggesting limited near-term disruption to sales and supply-chain activities. Stryker reports progress in restoration efforts after cyberattack
• Neutral Sentiment: Stryker announced its 2026 Annual Meeting of Shareholders — routine corporate governance news with limited direct impact on operational performance. Stryker announces Annual Meeting of Shareholders
• Neutral Sentiment: Analyst/sector pieces compare Stryker to peers (Envista, Intuitive Surgical) and discuss relative valuation and growth — useful for positioning but not an immediate catalyst. NVST or SYK: Which Is the Better Value Stock Right Now? Intuitive Surgical vs. Stryker
• Negative Sentiment: Coverage highlights that attackers are increasingly state-linked and aiming to disrupt enterprise operations or extract leverage — a reminder that containment doesn’t eliminate reputational, regulatory or longer-term operational risks. Stryker Cyberattack Highlights Criminal Focus on Enterprise Systems
• Negative Sentiment: Investors briefly bid the stock up after containment news, but later gave back gains as uncertainty about residual impacts (SEC disclosures, data exposure, remediation costs or supply interruptions) persisted. Stryker shares rise after containing cybersecurity incident Stryker Addresses and Contains Recent Cybersecurity Incident

Stryker Stock Down 1.3%

SYK stock opened at $328.35 on Wednesday. The stock has a market capitalization of $125.65 billion, a price-to-earnings ratio of 39.09, a price-to-earnings-growth ratio of 1.94 and a beta of 0.85. The company has a 50-day moving average of $362.13 and a two-hundred day moving average of $364.84. Stryker Corporation has a 52-week low of $327.21 and a 52-week high of $404.87. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.89 and a quick ratio of 1.21.

Stryker (NYSE:SYK) last posted its quarterly earnings data on Thursday, January 29th. The medical technology company reported $4.47 EPS for the quarter, topping analysts’ consensus estimates of $4.40 by $0.07. Stryker had a return on equity of 24.41% and a net margin of 12.92%.The business had revenue of $7.17 billion for the quarter, compared to analyst estimates of $7.12 billion. During the same period in the previous year, the company posted $4.01 earnings per share. The firm’s revenue for the quarter was up 11.4% on a year-over-year basis. As a group, equities research analysts anticipate that Stryker Corporation will post 13.47 EPS for the current year.

Stryker Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, April 30th. Shareholders of record on Tuesday, March 31st will be given a $0.88 dividend. This represents a $3.52 annualized dividend and a yield of 1.1%. The ex-dividend date of this dividend is Tuesday, March 31st. Stryker’s payout ratio is currently 41.90%.

Stryker Profile

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.